| pubmed-article:14981346 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C0007787 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C0035171 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C0948008 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C1511726 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C0070166 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C1442488 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C1273870 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C0332185 | lld:lifeskim |
| pubmed-article:14981346 | lifeskim:mentions | umls-concept:C1708943 | lld:lifeskim |
| pubmed-article:14981346 | pubmed:issue | 2-3 | lld:pubmed |
| pubmed-article:14981346 | pubmed:dateCreated | 2004-3-22 | lld:pubmed |
| pubmed-article:14981346 | pubmed:abstractText | The CAPRIE study showed the superiority of clopidogrel over acetylsalicylic acid (ASA) for reducing the combined risk of major atherothrombotic events in patients with recent myocardial infarction (MI), recent ischaemic stroke (IS) or established peripheral arterial disease. The benefit of clopidogrel over ASA is amplified in high-risk patients. Proof of concept for the benefit of clopidogrel in addition to ASA in patients with coronary manifestations of atherothrombosis was provided by the CURE trial. | lld:pubmed |
| pubmed-article:14981346 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14981346 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14981346 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14981346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14981346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14981346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14981346 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14981346 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14981346 | pubmed:issn | 1015-9770 | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:KasteMarkkuM | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:Bogousslavsky... | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:DienerHans-Ch... | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:BrassLawrence... | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:CimminielloCl... | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:RupprechtHans... | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:LeysDidierD | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:CsibaLaszloL | lld:pubmed |
| pubmed-article:14981346 | pubmed:author | pubmed-author:Matias-GuiuJo... | lld:pubmed |
| pubmed-article:14981346 | pubmed:copyrightInfo | Copyright 2004 S. Karger AG, Basel | lld:pubmed |
| pubmed-article:14981346 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14981346 | pubmed:volume | 17 | lld:pubmed |
| pubmed-article:14981346 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14981346 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14981346 | pubmed:pagination | 253-61 | lld:pubmed |
| pubmed-article:14981346 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:meshHeading | pubmed-meshheading:14981346... | lld:pubmed |
| pubmed-article:14981346 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:14981346 | pubmed:articleTitle | Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): study design and baseline data. | lld:pubmed |
| pubmed-article:14981346 | pubmed:affiliation | Department of Neurology, University of Essen, Germany. h.diener@uni-essen.de | lld:pubmed |
| pubmed-article:14981346 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14981346 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:14981346 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:14981346 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
